You are here

Our science / Clinical Trials / Find a Trial / NCT01421303

Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.

Back to Search Print Save as PDF Bookmark Trial

NCT01421303

Last updated on December 6, 2018
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Universitair Ziekenhuis Gent
Gent, , 9000 Belgium
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Ankylosing Spondylitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Active AS patients (as judged by the treating MD) who are currently employed.

- Patients who are scheduled by their rheumatologist to initiate treatment with
Etanercept.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients who initiated a procedure for eligibility of work disability/pension.

- Patients with previous use of TNF-alpha inhibitors either in commercial use, or in a
study for the treatment of AS or a related spondylarthropathy condition.

NCT01421303
Pfizer
Completed
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Similar Trials

Ankylosing Spondylitis
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
NCT00420238
All Genders
18+
Years
Multiple Sites
Ankylosing Spondylitis, Psoriatic Arthritis, Rheumatoid Arthritis
Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia
NCT00751387
All Genders
18+
Years
Multiple Sites
Ankylosing Spondylitis
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
NCT00900796
All Genders
18+
Years
Madrid,
Ankylosing Spondylitis
Study Investigating Enbrel Treatment for Ankylosing Spondylitis
NCT00195416
All Genders
18+
Years
Multiple Sites
Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
Work Productivity In A Cohort Of Employed Ankylosing Spondylitis Patients Treated With Etanercept
Patients with Ankylosing spondylitis more frequently discontinue work. This study measures the impact of Enbrel on work participation.
Purely descriptive
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
AS patients visiting the rheumatologist for which the decision has been taken to prescribe Enbrel
Ankylosing Spondylitis
Drug: Enbrel
Enbrel
AS patients who are working and treated with Enbrel
Intervention: Drug: Enbrel
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
December 2013
December 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Active AS patients (as judged by the treating MD) who are currently employed.
  • Patients who are scheduled by their rheumatologist to initiate treatment with Etanercept.

Exclusion Criteria:

  • Patients who initiated a procedure for eligibility of work disability/pension.
  • Patients with previous use of TNF-alpha inhibitors either in commercial use, or in a study for the treatment of AS or a related spondylarthropathy condition.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Belgium
 
 
NCT01421303
0881A3-4675
B1801053 ( Other Identifier: Alias Study Number )
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
December 2014

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now